Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
You worry about the shorters far to much they are part of the share price.... making on the retracements... but remember we have risen from 58p and the share chart is positive...nothing goes up in a straight line....
And when covid is controlled banks will flourish......bbc news extract
"Prime Minister Boris Johnson says he is "optimistic" people will be able to have summer holidays this year - but it depends on certain things going well.
Asked about tourism in the UK, he said he did not want to give "concrete" dates for such trips but would set out more details on 22 February.
The success of the vaccine rollout and level of Covid cases would be factors taken into consideration, he added.
Nearly 9.3 million people in the UK have had their first dose of a vaccine."
90% of covid deaths are in the over 65 category ...So vaccinating this group foremost would take a lot of pressure of the NHS.....wether the younger generation decide not to take the vaccine is not a problem as long as the older groups are protected and have the vaccine which... imo ....most will...
What is the new Covid-19 strain and will it respond to the vaccine?
The variant was first spotted in late September and it is highly unlikely that this mutation would fail to respond to a vaccine
By
Telegraph Reporters
19 December 2020 • 3:00pm
Shoppers in Chelmsford
Shoppers in Chelmsford CREDIT: John Keeble /Getty Images Europe
Q: What is the Covid-19 mutant strain?
A: It has been named VUI-202012/01 (the first “Variant Under Investigation” in December 2020) and is defined by a set of 17 changes or mutations. As of Dec 13, a total of 1,108 cases with this new variant had been identified, predominantly in the south and east of England where cases have been rising.
Q: When did the new strain emerge?
A: The variant was first spotted in late September and now accounts for 20% of viruses sequenced in Norfolk, 10% in Essex, and 3% in Suffolk. There is no evidence that it was imported from abroad, so is likely to have evolved in the UK.
Q: How is it different from the original Covid-19 virus?
A: Public Health England say this new strain may result in the virus becoming more infectious and spreading more easily between people. This does not necessarily mean it is more dangerous or will result in more deaths.
Q: Is it something to worry about?
ADVERTISING
A: There have been many mutations in the Covid-19 virus since it emerged in 2019 and it is not at all uncommon for this to happen. There is nothing to suggest this new strain is more likely to cause serious disease. However, if the new strain spreads more easily then it's possible more people will end up being infected in a shorter period of time.
Q: Why is this strain getting so much attention?
A: While other variants have been identified in the past, it appears this particular strain is spreading quite fast, meaning it could be more transmissible, and therefore warrants further investigation. Prof Sir Mark Walport - a member of the Government's Scientific Advisory Group for Emergencies (Sage) - said there was a possibility that it could have a "transmission advantage".
Q: Will the vaccine be affected?
A: It is highly unlikely that this mutation would fail to respond to a vaccine. The vaccine produces antibodies against many regions in the spike protein, and it is unlikely a single change would make the vaccine less effective.
Q: What are scientists doing now?
A: They are growing the new strain in the lab to see how it responds. This includes looking at whether it produces the same antibody response and how it reacts to the vaccine. It could take up to two weeks for this thorough process to be complete. Experts say the strain could be "useful as a barcode to monitor outbreaks".
Q: Why do viruses mutate?
A: Mutations in viruses are a natural part of evolution. The pressure on the virus to evolve is increased by the fact that so many millions of people have now been infected.
Global Health Bulletin
Get the latest coronavirus news and adv
From the independent
A vaccine a developed by the University of Oxford is set to be approved within days of Christmas, according to senior Whitehall sources.
The Medicines and Healthcare Regulatory Agency (MHRA) is believed to be set to authorise the vaccines on December 28 or 29 after final data is provided to the regulator on Monday.
Football stadiums and other sites across the country will then be opened from the first week of January, to allow mass vaccinations on a scale never seen before in the UK, according to the Telegraph.
The UK has secured 100 million doses of the jab, four million of which are immediately available, allowing a major expansion in the NHS vaccine programme across the country.
ADVERTISING
With more approvals for more vaccines to come and the old and at risk being vaccinated soon.... even Boris is saying covid will look better by Easter....not long as the markets look forward...as for brexit there is still a deal to be done?
I like this bit from the RNS..
".The 2.7% premium on gross book value results in an estimated £83 million gain on sale. On completion, the disposal is expected to result in a 30 September 2020 pro-forma improvement in Metro Bank's total capital plus MREL ratio of 400bps from 20.2% to 24.2%, and a 30 September 2020 pro-forma CET1 ratio of 16.3%. The transaction removes any current need to issue MREL qualifying debt."
The timing of the RNS gives the weekend press chance to comment on the deal ?,......also good timing considering the BOE announcement on MREL........bring on monday when shorters wil be squeezed and punters who sold out looking for a lower price will buy back in.....
Extract from BBC News
"There are two key sticking points preventing an agreement - competition rules and fishing rights - and negotiators will now continue to sort these issues out.
But, making a statement from the Commission in Brussels, Mrs von der Leyen said the call with Mr Johnson had been "constructive and useful".
She added: "Despite the exhaustion after almost a year of negotiations, despite the fact that deadlines have been missed over and over, we think it is responsible at this point to go the extra mile."